{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:59Z","timestamp":1740107339607,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T00:00:00Z","timestamp":1495238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00223-017-0290-3","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T02:46:38Z","timestamp":1495248398000},"page":"422-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Direct Comparison of the Effects of the Antiretroviral Drugs Stavudine, Tenofovir and the Combination Lopinavir\/Ritonavir on Bone Metabolism in a Rat Model"],"prefix":"10.1007","volume":"101","author":[{"given":"M. M.","family":"Conradie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0861-2939","authenticated-orcid":false,"given":"M.","family":"van de Vyver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Andrag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3092-4098","authenticated-orcid":false,"given":"M.","family":"Conradie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-5239","authenticated-orcid":false,"given":"W. F.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,20]]},"reference":[{"issue":"11","key":"290_CR1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/j.1532-5415.2009.02494.x","volume":"57","author":"JB Kirk","year":"2009","unstructured":"Kirk JB, Goetz MB (2009) Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 57(11):2129\u20132138","journal-title":"J Am Geriatr Soc"},{"key":"290_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/CIA.S13852","volume":"5","author":"KC Mansky","year":"2010","unstructured":"Mansky KC (2010) Aging, human immunodeficiency virus, and bone health. Clin Interv Aging 5:285\u2013292","journal-title":"Clin Interv Aging"},{"issue":"8","key":"290_CR3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","volume":"12","author":"L Aurpibul","year":"2007","unstructured":"Aurpibul L, Puthanakit T, Lee B, Mangklabruks A, Sirisanthana T, Sirisanthana V (2007) Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther 12(8):1247\u20131254","journal-title":"Antivir Ther"},{"issue":"9","key":"290_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","volume":"163","author":"PC Tien","year":"2006","unstructured":"Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C (2006) The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol 163(9):860\u2013869","journal-title":"Am J Epidemiol"},{"issue":"3","key":"290_CR5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jc.2003-031506","volume":"89","author":"TT Brown","year":"2004","unstructured":"Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS et al (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab 89(3):1200\u20131206","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"290_CR6","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2000","unstructured":"Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL et al (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS Lond Engl 14(4):F63\u2013F67","journal-title":"AIDS Lond Engl"},{"issue":"5","key":"290_CR7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","volume":"74","author":"AY McDermott","year":"2001","unstructured":"McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S (2001) Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am J Clin Nutr 74(5):679\u2013686","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"290_CR8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","volume":"35","author":"MP Dub\u00e9","year":"2002","unstructured":"Dub\u00e9 MP, Qian D, Edmondson-Melan\u00e7on H, Sattler FR, Goodwin D, Martinez C et al (2002) Prospective, intensive study of metabolic changes associated with 48\u00a0weeks of amprenavir-based antiretroviral therapy. Clin Infect Dis Off Publ Infect Dis Soc Am 35(4):475\u2013481","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"290_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","volume":"68","author":"NT Funderburg","year":"2015","unstructured":"Funderburg NT, Jiang Y, Debanne SM, Labbato D, Juchnowski S, Ferrari B et al (2015) Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr 68(4):396\u2013404","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"290_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/infdis\/jiw096","volume":"214","author":"V Mave","year":"2016","unstructured":"Mave V, Erlandson KM, Gupte N, Balgopal A, Asmuth DM, Campbell TB et al (2016) Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults. J Infect Dis 214(1):65\u201372","journal-title":"J Infect Dis"},{"issue":"17","key":"290_CR11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS Lond Engl 20(17):2165\u20132174","journal-title":"AIDS Lond Engl"},{"issue":"6","key":"290_CR12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0736-0266(02)00074-8","volume":"20","author":"AB Castillo","year":"2002","unstructured":"Castillo AB, Tarantal AF, Watnik MR, Martin RB (2002) Tenofovir treatment at 30\u00a0mg\/kg\/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta). J Orthop Res Off Publ Orthop Res Soc 20(6):1185\u20131189","journal-title":"J Orthop Res Off Publ Orthop Res Soc"},{"issue":"22","key":"290_CR13","doi-asserted-by":"crossref","first-page":"19247","DOI":"10.1074\/jbc.C200069200","volume":"277","author":"RG Jain","year":"2002","unstructured":"Jain RG, Lenhard JM (2002) Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J Biol Chem 277(22):19247\u201319250","journal-title":"J Biol Chem"},{"issue":"5","key":"290_CR14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","volume":"51","author":"TT Brown","year":"2009","unstructured":"Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, da Silva BA (2009) Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr 51(5):554\u2013561","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"290_CR15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","volume":"23","author":"B Grund","year":"2009","unstructured":"Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC et al (2009) Continuous antiretroviral therapy decreases bone mineral density. AIDS Lond Engl 23(12):1519\u20131529","journal-title":"AIDS Lond Engl"},{"issue":"4","key":"290_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/COH.0b013e3283478741","volume":"6","author":"J Hoy","year":"2011","unstructured":"Hoy J (2011) Bone, fracture and frailty. Curr Opin HIV AIDS 6(4):309\u2013314","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"290_CR17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"GA McComsey","year":"2011","unstructured":"McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P et al (2011) Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis 203(12):1791\u20131801","journal-title":"J Infect Dis"},{"issue":"9","key":"290_CR18","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1210\/jc.2011-0591","volume":"96","author":"MJ Bolland","year":"2011","unstructured":"Bolland MJ, Wang TKM, Grey A, Gamble GD, Reid IR (2011) Stable bone density in HAART-treated individuals with HIV: a meta-analysis. J Clin Endocrinol Metab 96(9):2721\u20132731","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"290_CR19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","volume":"49","author":"A Martin","year":"2009","unstructured":"Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S et al (2009) Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial. Clin Infect Dis Off Publ Infect Dis Soc Am 49(10):1591\u20131601","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"290_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0b013e3181bf6471","volume":"53","author":"MT Yin","year":"2010","unstructured":"Yin MT, Lu D, Cremers S, Tien PC, Cohen MH, Shi Q et al (2010) Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr 53(2):202\u2013208","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"290_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","volume":"51","author":"H-J Stellbrink","year":"2010","unstructured":"Stellbrink H-J, Orkin C, Arribas JR, Compston J, Gerstoft J, Van Wijngaerden E et al (2010) Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis Off Publ Infect Dis Soc Am 51(8):963\u2013972","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"12","key":"290_CR22","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115(12):3318\u20133325","journal-title":"J Clin Invest"},{"issue":"13","key":"290_CR23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","volume":"17","author":"D Bruera","year":"2003","unstructured":"Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS Lond Engl 17(13):1917\u20131923","journal-title":"AIDS Lond Engl"},{"issue":"9","key":"290_CR24","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","volume":"93","author":"VA Triant","year":"2008","unstructured":"Triant VA, Brown TT, Lee H, Grinspoon SK (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93(9):3499\u20133504","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"290_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hiv.12242","volume":"16","author":"A Carr","year":"2015","unstructured":"Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D et al (2015) Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med 16(Suppl 1):137\u2013146","journal-title":"HIV Med"},{"issue":"1","key":"290_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/COH.0000000000000028","volume":"9","author":"AG Cotter","year":"2014","unstructured":"Cotter AG, Mallon PWG (2014) The effects of untreated and treated HIV infection on bone disease. Curr Opin HIV AIDS 9(1):17\u201326","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"290_CR27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0000000000000320","volume":"28","author":"CO Hileman","year":"2014","unstructured":"Hileman CO, Labbato DE, Storer NJ, Tangpricha V, McComsey GA (2014) Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS Lond Engl 28(12):1759\u20131767","journal-title":"AIDS Lond Engl"},{"issue":"3","key":"290_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0000000000000275","volume":"11","author":"T McGinty","year":"2016","unstructured":"McGinty T, Mirmonsef P, Mallon PWG, Landay AL (2016) Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS 11(3):253\u2013260","journal-title":"Curr Opin HIV AIDS"},{"issue":"4 Suppl 3","key":"290_CR29","doi-asserted-by":"crossref","first-page":"19569","DOI":"10.7448\/IAS.17.4.19569","volume":"17","author":"C Pinnetti","year":"2014","unstructured":"Pinnetti C, Federico L, Lorenzini P, Domenico C, Rita B, Laura L et al (2014) Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA. J Int AIDS Soc 17(4 Suppl 3):19569","journal-title":"J Int AIDS Soc"},{"key":"290_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2047-783X-14-2-59","volume":"14","author":"J Teichmann","year":"2009","unstructured":"Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG (2009) Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART). Eur J Med Res 14:59\u201364","journal-title":"Eur J Med Res"},{"key":"290_CR31","unstructured":"What to start: initial combination regimens for the antiretroviral-naive patient|adult and adolescent ARV guidelines [Internet]. AIDSinfo. [cited 2016 Aug 24]. https:\/\/aidsinfo.nih.gov\/"},{"issue":"2","key":"290_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7(2):27\u201331","journal-title":"J Basic Clin Pharm"},{"issue":"1","key":"290_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/10520299209110002","volume":"67","author":"HE Gruber","year":"1992","unstructured":"Gruber HE (1992) Adaptations of Goldner\u2019s Masson trichrome stain for the study of undecalcified plastic embedded bone. Biotech Histochem Off Publ Biol Stain Comm 67(1):30\u201334","journal-title":"Biotech Histochem Off Publ Biol Stain Comm"},{"issue":"1","key":"290_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H et al (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res Off J Am Soc Bone Miner Res 28(1):2\u201317","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"290_CR35","unstructured":"WHO|New HIV recommendations to improve health, reduce infections and save lives [Internet]. WHO. [cited 2016 Aug 24]. http:\/\/www.who.int\/mediacentre\/news\/releases\/2009\/world_aids_20091130\/en\/"},{"key":"290_CR36","unstructured":"Dieterich DT (2003) Long-term complications of nucleoside reverse transcriptase inhibitor therapy. AIDS Read 13(4):176\u2013184, 187"},{"issue":"3","key":"290_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14740338.2011.542145","volume":"10","author":"A Curran","year":"2011","unstructured":"Curran A, Ribera E (2011) From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir. Expert Opin Drug Saf 10(3):389\u2013406","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"290_CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-8587(14)70007-5","volume":"3","author":"MJ Devlin","year":"2015","unstructured":"Devlin MJ, Rosen CJ (2015) The bone-fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 3(2):141\u2013147","journal-title":"Lancet Diabetes Endocrinol."},{"key":"290_CR39","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K et al (2013) Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation. Cell Death Dis 4:e832","journal-title":"Cell Death Dis"},{"issue":"2","key":"290_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/JOE-14-0425","volume":"223","author":"M Vyver van de","year":"2014","unstructured":"van de Vyver M, Andrag E, Cockburn IL, Ferris WF (2014) Thiazolidinedione-induced lipid droplet formation during osteogenic differentiation. J Endocrinol 223(2):119\u2013132","journal-title":"J Endocrinol"},{"issue":"2","key":"290_CR41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yexcr.2015.07.031","volume":"337","author":"L Gibellini","year":"2015","unstructured":"Gibellini L, De Biasi S, Nasi M, Carnevale G, Pisciotta A, Bianchini E et al (2015) Different origin of adipogenic stem cells influences the response to antiretroviral drugs. Exp Cell Res 337(2):160\u2013169","journal-title":"Exp Cell Res"},{"key":"290_CR42","unstructured":"Tjen-A-Looi A. Hypophosphatemic osteomalacia associated with Tenofovir use in HIV infected patients: a case series and review of the literature. J AIDS Clin Res [Internet]. 2012 [cited 2016 Sep 19];1(S4). http:\/\/www.omicsonline.org\/2155-6113\/2155-6113-S4-008.digital\/2155-6113-S4-008.html"},{"issue":"13","key":"290_CR43","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","volume":"15","author":"AL Moore","year":"2001","unstructured":"Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN et al (2001) Reduced bone mineral density in HIV-positive individuals. AIDS Lond Engl 15(13):1731\u20131733","journal-title":"AIDS Lond Engl"},{"issue":"2","key":"290_CR44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI15797","volume":"114","author":"MW-H Wang","year":"2004","unstructured":"Wang MW-H, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG et al (2004) The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J Clin Invest 114(2):206\u2013213","journal-title":"J Clin Invest"},{"issue":"5","key":"290_CR45","doi-asserted-by":"crossref","first-page":"e63623","DOI":"10.1371\/journal.pone.0063623","volume":"8","author":"R Waal de","year":"2013","unstructured":"de Waal R, Cohen K, Maartens G (2013) Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS ONE 8(5):e63623","journal-title":"PLoS ONE"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0290-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T19:19:23Z","timestamp":1659035963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0290-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,20]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0290-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2017,5,20]]}}}